Beyond IGF-1R: IL-6R Inhibition and Future Sequencing

Faculty: Prem S. Subramanian, MD, PhD


Faculty: Kimberly Cockerham, MD

Join our experts as they explore why clinical activity scores (CAS) alone often fail to capture the full impact of thyroid eye disease (TED) severity and what tools can help align treatment with patients’ true disease burden. See how emerging TED therapies and the latest clinical trial data are reshaping patient-centered care. Discover how our experts streamline clinic workflows, reduce infusion burden, and coordinate care to improve patient outcomes.